Buprenorphine and pregnancy. Analysis of 24 cases

Citation
M. Jernite et al., Buprenorphine and pregnancy. Analysis of 24 cases, ARCH PED, 6(11), 1999, pp. 1179-1185
Citations number
41
Categorie Soggetti
Pediatrics
Journal title
ARCHIVES DE PEDIATRIE
ISSN journal
0929693X → ACNP
Volume
6
Issue
11
Year of publication
1999
Pages
1179 - 1185
Database
ISI
SICI code
0929-693X(199911)6:11<1179:BAPAO2>2.0.ZU;2-H
Abstract
Background. - Maintenance therapy of drug-addict mothers with medical and p sychosocial support may reduce complications (prematurity, growth retardati on, fetal distress and fetal death). Methadone has been widely used during pregnancy with beneficial effects. Buprenorphine (BUP) is used more and mor e and shows the same beneficial effects. Patients and method. - Twenty-four pregnant women received BUP and their in fants were enrolled in the study. Thirteen retrospective (GI) and 11 prospe ctive (GII) cases were studied. In the GII, the women were treated and foll owed up in an interdisciplinary manner. Results. - Complications in GII were less frequent than in GI: 9 vs 30% of prematurity, 9 vs 46% of fetal growth retardation and 0 vs 23% of acute fet al distress. However, the frequency of withdrawal syndrome was the same in both groups, 63 vs 69%, though improvements came more rapidly in GII. Conclusion. - This study shows that the use of BUP during pregnancy, combin ed with medical and psychosocial support, may reduce addiction complication s. This support has to be maintained after the birth. (C) 1999 Editions sci entifiques et medicales Elsevier SAS.